NYSE$HLF

Herbalife Nutrition Ltd. · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

Herbalife reported Q4 net sales at the high end of guidance, with Q4 and full-year net sales growth excluding FX headwinds, and Q4 adjusted EBITDA exceeded guidance.

Herbalife reported fourth quarter 2024 net sales of $1.2 billion, a slight decrease of 0.6% year-over-year, but an increase of 2.7% on a constant currency basis. Adjusted EBITDA of $150.0 million exceeded guidance, with the adjusted EBITDA margin up 340 basis points compared to Q4 2023. Diluted EPS was $1.74, and adjusted diluted EPS was $0.36.

  • Net sales for Q4 2024 were $1.2 billion, down 0.6% year-over-year, but up 2.7% on a constant currency basis, reaching the high end of guidance.
  • Adjusted EBITDA for Q4 2024 was $150.0 million, exceeding guidance, with the adjusted EBITDA margin increasing by 340 basis points compared to Q4 2023.
  • Diluted EPS for Q4 2024 was $1.74, and adjusted diluted EPS was $0.36.
  • The company reported three consecutive quarters of new distributor growth, with a 22% year-over-year increase in new distributors joining worldwide in Q4.

Headline financials

Total Revenue

$1.21B

Previous: $1.22B-0.6%
EPS (adj)

$0.36

Previous: $0.28+28.6%
Adjusted EBITDA Margin

12.4%

Previous: 9.0%+37.8%
Gross Profit Margin

77.8%

No prior period
Net Income

$178M

Previous: $10.2M+1644.1%
Operating Income

$107M

Previous: $55.8M+90.9%
Gross Profit

$940M

Previous: $927M+1.3%

Revenue & EPS history

Herbalife · Revenue · Quarterly

$1.21B

Q4 2024-0.6%vs Q4 2023
Beat estimate in 10 of 14 quarters(71%)
ActualEstimate

Forward guidance

For Q1 2025, Herbalife expects net sales to decline by 5.5% to 1.5% year-over-year, but to be flat to up 4% on a constant currency basis. Adjusted EBITDA is projected to be between $140 million and $150 million, or $158 million to $168 million at constant currency. For the full year 2025, net sales are expected to be down 3% to up 3% year-over-year, or up 1% to 7% at constant currency. Adjusted EBITDA is projected to be between $600 million and $640 million, or $670 million to $710 million at constant currency.

Tailwinds

  • Net sales at constant currency are expected to grow 0% to +4% YoY in Q1 2025.
  • Net sales at constant currency are expected to grow +1% to +7% YoY for the full year 2025.
  • Adjusted EBITDA at constant currency is projected to be $158-$168 million for Q1 2025.
  • Adjusted EBITDA at constant currency is projected to be $670-$710 million for the full year 2025.
  • The company expects to incur total capitalized SaaS implementation costs of approximately $25 million to $30 million for the full year of 2025, which are not included in capital expenditures.

Headwinds

  • Net sales are expected to decline (5.5)% to (1.5)% YoY in Q1 2025.
  • Net sales are expected to decline (3)% to +3% YoY for the full year 2025.
  • Outlook does not include any potential impact of incremental tariffs.
  • Capital expenditures are projected to be $30-$40 million for Q1 2025.
  • Capital expenditures are projected to be $100-$130 million for the full year 2025.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+2.4%

Avg return

Earnings day

+0.3%

Avg return

5 days after

-1.5%

Avg return

30 days after

53%

36 / 68 earnings

Positive

+42.7%

Q4 2024

Best reaction

-31.9%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.2%-17.2%-30.7%
Q4 2025+18.3%+18.5%-11.1%
Q3 2025+10.7%+10.0%+48.1%
Q1 2025-7.9%-4.7%+8.5%
Q4 2024+42.7%+47.5%+50.0%
Q3 2024+8.5%+18.2%+11.6%
Q2 2024-9.4%-22.8%-34.1%
Q1 2024+8.4%+12.4%+19.1%
Q4 2023-31.9%-31.6%-24.1%
Q3 2023-2.5%-3.3%-7.7%
Q2 2023+14.8%+13.3%-5.7%
Q1 2023-8.6%-6.4%-20.8%
Q4 2022+27.1%+22.0%+7.3%
Q3 2022-2.8%-24.5%-18.5%
Q2 2022+12.0%+13.2%+7.2%
Q1 2022-3.4%-8.7%-16.3%
Q4 2021-16.7%-14.5%-25.8%
Q3 2021-3.7%-5.3%-17.6%
Q2 2021-5.7%-5.2%+2.9%
Q1 2021+3.2%+9.1%+18.0%
Q4 2020-10.5%-18.6%-17.7%
Q3 2020+2.1%-6.0%+5.1%
Q2 2020-3.4%-5.2%-4.6%
Q1 2020+22.0%+16.4%+35.3%
Q4 2019-2.8%-5.6%-26.3%
Q3 2019+10.6%+9.4%+13.0%
Q2 2019-7.4%-6.6%-16.1%
Q1 2019-5.9%-6.7%-22.2%
Q4 2018-0.9%-0.6%-1.0%
Q3 2018-1.9%-1.5%+4.8%
Q2 2018+11.8%+15.0%+9.6%
Q1 2018+5.1%+4.6%-3.9%
Q4 2017+3.2%+4.5%+18.0%
Q3 2017-3.4%-6.5%-1.7%
Q2 2017-1.9%-0.9%+3.8%
Q1 2017+11.2%+16.6%+18.4%
Q4 2016-6.6%-7.0%-6.1%
Q3 2016-8.6%-9.4%-20.5%
Q2 2016+1.1%+0.4%-8.1%
Q1 2016+9.9%
Q4 2015+19.3%
Q3 2015-1.7%
Q2 2015+14.4%
Q1 2015+11.0%
Q4 2014-7.9%
Q3 2014-15.6%
Q2 2014-11.7%
Q1 2014+4.0%
Q4 2013-0.3%
Q3 2013+2.4%
Q2 2013+2.7%
Q1 2013+3.8%
Q4 2012-2.5%
Q3 2012+1.5%
Q2 2012+2.0%
Q1 2012-15.3%
Q4 2011+10.2%
Q3 2011-5.4%
Q2 2011+5.3%
Q1 2010+13.9%
Q1 2011-0.7%
Q4 2008+10.6%
Q4 2010+10.6%
Q3 2009-1.7%
Q3 2010-1.7%
Q2 2009+10.7%
Q2 2010+10.7%
Q4 2009+10.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro